Welcome To Welox Pharma WHO-GMP | ISO 9001:2015
Translated into:
Welcome To Welox Pharma WHO-GMP | ISO 9001:2015
Introduction to Welcigo Plus Tablets
Welcigo Plus Tablets are a trusted antimalarial combination for treating uncomplicated malaria, especially in regions with drug-resistant Plasmodium falciparum. With Mefloquine and Artesunate, this dual-action therapy ensures rapid clearance of malaria parasites and long-lasting protection.
Uses of Welcigo Plus Tablets
Treatment of uncomplicated Plasmodium falciparum malaria
Suitable for areas with known drug-resistant malaria strains
Helps reduce the burden of parasitemia and prevents recrudescence
Recommended as part of combination antimalarial therapy to enhance efficacy and minimize resistance
Benefits of Welcigo Plus Tablets
Fast-acting Artesunate quickly clears parasites, alleviating symptoms
Long-acting Mefloquine ensures prolonged protection against recrudescence
Combination therapy approach for superior efficacy against P. falciparum malaria
Proven clinical safety and effectiveness in treating uncomplicated malaria
Reduces the risk of treatment failure and helps maintain high cure rates
Mechanism of Action of Welcigo Plus Tablets
Artesunate targets the parasite’s early blood stages, leading to rapid clearance of parasitemia.
Mefloquine remains active in the bloodstream for extended periods, suppressing residual parasites and preventing relapse.
Together, they provide a balanced approach that tackles malaria quickly and maintains long-term protection.
For best results, take Welcigo Plus Tablets as prescribed by your healthcare provider. Store in a cool, dry place and ensure full adherence to the recommended treatment course.